Lincomycin HCl is a narrow-spectrum antibiotic, has similar effects to erythromycin, which has a good effect on Gram-positive coccus, mainly used to inhibit the synthesis of bacterial cell protein.
Lincomycin HCl H2O is a lincosamide antibiotics used in clinical practice. It is bacteriostatic and inhibit protein synthesis in sensitive bacteria. It may even be bactericidal at the higher concentrations that can be reached in vivo[2]. Lincomycin and its derivatives are antibiotics exhibiting biological activity against Gram-positive bacteria. The semi-synthetic chlorinated lincomycin derivative is used in clinical practice[3]. Peak plasma level of lincomycin (71.8 ± 1.83 μg/mL) was observed at 1 min as expected by IV route. The elimination half-life and MRT of lincomycin were short (3.30 ± 0.08 and 4.32 ± 0.11 h, respectively). Lincomycin 10 mg/kg IV at 12-h interval would be sufficient to maintain T > MIC above 60 % for bacteria with minimum inhibitory concentrations (MIC) values ≤1.6 μg/mL. Lincomycin may be an appropriate antibacterial in buffalo species for gram-positive and anaerobic bacterial pathogens susceptible to lincomycin[4]. The place of lincomycin in therapeutics seems to be principally in the treatment of chronic osteomyelitis and, in patients allergic to the penicillins, in the treatment of staphylococcal, respiratory and other infections for which penicillin is usually employed[5].
搜索
